Clinical Trials Directory

Trials / Completed

CompletedNCT02941432

Black Tea Compresses for Facial Eczema and Perioral Dermatitis

Pilot Study of Effects and Tolerance of Black Tea Compress Treatment in Facial Eczema and Perioral Dermatitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
University of Luebeck · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Facial eczema and perioral dermatitis are clinical entities that develop exclusively in the face and present a special therapeutic challenge. Topical corticosteroids that are commonly applied to treat eczema/dermatitis at other body sites are best avoided in the face, as they may result in rapid atrophy of facial skin and in the long term rather aggravate facial dermatoses. Black tea compresses have been successfully used by German-speaking dermatologists to treat facial eczema/dermatitis for decades. The precise mechanism of action is unknown but is presumably based on astringent properties of tannins in the black tea and on the antiinflammatory action of a wet compress as such. This therapy is cheap, universally available and practically free of side-effects. Despite these perceived advantages the effects and tolerance of black tea compresses have not been formally studied to date. Therefore, the investigators plan to treat 25 patients with facial eczema/perioral dermatitis over a period of 6 days each within the current trial. The disease activity will be assessed before, during and after completion of treatment using several clinical scores. In addition, side-effects, if any, will be documented.

Conditions

Interventions

TypeNameDescription
OTHERBlack tea compress treatmentWet compresses with black tea applied 4-5 times daily to the face for 6 days

Timeline

Start date
2016-09-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2016-10-21
Last updated
2017-11-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02941432. Inclusion in this directory is not an endorsement.